Associated Papers
Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes.
Aizenbud L et al.
Journal for Immunotherapy of Cancer, 2025
NLRC5 germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors.
Meng XY
Journal for Immunotherapy of Cancer, 2023
Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors.
Caulfield JI et al.
Journal for Immunotherapy of Cancer, 2023
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia.
Fontana D et al.
Hemasphere, 2020
33196013 (PubMed )
Supplement: hs9-4-e497-s007.xlsx › Sheet1
TBX1 mutation identified by exome sequencing in a Japanese family with 22q11.2 deletion syndrome-like craniofacial features and hypocalcemia.
Ogata T et al.
Plos One, 2014
24637876 (PubMed )
Supplement: pone.0091598.s007.pdf
Select a paper to view details